- Home
- WFF vs ACTU Comparison
WFF vs ACTU Comparison
Compare WFF & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- ACTU
- Stock Information
- Founded
- WFF 1984
- ACTU 2015
- Country
- WFF Malaysia
- ACTU United States
- Employees
- WFF N/A
- ACTU N/A
- Industry
- WFF Miscellaneous manufacturing industries
- ACTU
- Sector
- WFF Consumer Discretionary
- ACTU
- Exchange
- WFF Nasdaq
- ACTU NYSE
- Market Cap
- WFF 155.9M
- ACTU 135.0M
- IPO Year
- WFF 2025
- ACTU 2024
- Fundamental
- Price
- WFF $2.45
- ACTU $6.39
- Analyst Decision
- WFF
- ACTU Strong Buy
- Analyst Count
- WFF 0
- ACTU 1
- Target Price
- WFF N/A
- ACTU $20.00
- AVG Volume (30 Days)
- WFF 2.2M
- ACTU 133.1K
- Earning Date
- WFF 01-01-0001
- ACTU 05-15-2025
- Dividend Yield
- WFF N/A
- ACTU N/A
- EPS Growth
- WFF N/A
- ACTU N/A
- EPS
- WFF 0.00
- ACTU N/A
- Revenue
- WFF $4,572,290.00
- ACTU N/A
- Revenue This Year
- WFF N/A
- ACTU N/A
- Revenue Next Year
- WFF N/A
- ACTU N/A
- P/E Ratio
- WFF $900.59
- ACTU N/A
- Revenue Growth
- WFF N/A
- ACTU N/A
- 52 Week Low
- WFF $1.91
- ACTU $5.50
- 52 Week High
- WFF $29.26
- ACTU $11.99
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- ACTU N/A
- Support Level
- WFF N/A
- ACTU N/A
- Resistance Level
- WFF N/A
- ACTU N/A
- Average True Range (ATR)
- WFF 0.00
- ACTU 0.00
- MACD
- WFF 0.00
- ACTU 0.00
- Stochastic Oscillator
- WFF 0.00
- ACTU 0.00
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.